Thyssenkrupp Nucera recorded stable operational performance in the third quarter of 2024/2025. According to preliminary figures, revenue amounted to €184 million, and earnings before interest and taxes (EBIT) stood at €0 million. Order intake totaled €63 million, significantly below the previous year’s figure of €271 million.
In the green hydrogen (gH2) segment, the company generated revenue of €103 million (previous year: €134 million) and an EBIT of –€13 million (previous year: –€23 million). In the chlor-alkali (CA) segment, revenue amounted to €81 million (previous year: €103 million), with EBIT at €13 million (previous year: €25 million). In the previous year, one-off effects had a positive impact on the CA segment’s earnings.
In the first nine months of the current fiscal year, group revenue rose to €663 million (previous year: €609 million). EBIT improved to €4 million (previous year: –€13 million). As of June 30, 2025, the order backlog stood at approximately €700 million.
Revenue forecast for full year lowered
Against the backdrop of continued subdued investment activity in the green hydrogen sector, Thyssenkrupp Nucera has adjusted its forecast for fiscal year 2024/2025. The group now expects annual revenue between €850 million and €920 million. Previously, the upper range was €950 million. In the previous year, the company generated €862 million in revenue.
For the green hydrogen segment, revenue is now expected to range between €450 million and €510 million. Previously, the upper limit was €550 million. Last year, the segment generated €524 million. The EBIT forecast for gH2 is now between –€75 million and –€55 million. In the previous year, EBIT stood at –€76 million.
In the chlor-alkali segment, the revenue forecast remains unchanged at €380 million to €420 million. EBIT is now expected to range between €55 million and €75 million. Previously, a mid-double-digit million amount below the previous year’s figure of €62 million had been expected. “By specifying our revenue and EBIT forecast for our two segments, green hydrogen (gH2) and chlor-alkali (CA), we are further increasing our transparency. The upward revision of the EBIT forecast highlights our stable operational performance,” says Stefan Hahn, CFO of Thyssenkrupp Nucera.
Thyssenkrupp Nucera hopes for more dynamic order development
Despite the current reluctance to make final investment decisions in the hydrogen market, the company sees potential for more dynamic order development. “An expected more dynamic order development in both the green hydrogen and chlor-alkali segments, along with our consistent cost management, should continue to enable us to achieve high-margin growth,” says Werner Ponikwar, CEO of Thyssenkrupp Nucera.
Final figures for the third quarter of 2024/2025 are still pending. The published figures are based on preliminary, unaudited financial data.
